SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥146.87+CN¥3.98 (+2.79%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 15.62% below the high.
Loading market information…
HKSE · 6609.HK · HKD
Stock price, earnings
Quote as of Oct 30, 2026, 03:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Shanghai HeartCare Medical Technology Corporation Limited’s quoted price sits in the upper half of its reported 52-week range, 25.89% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Shanghai HeartCare Medical Technology Corporation Limited’s next earnings report is currently expected on Apr 1, 2027, with estimated earnings per share of -HK$1.30. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shanghai HeartCare Medical Technology Corporation Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Shanghai HeartCare Medical Technology Corporation Limited is a global enterprise specializing in the research, development, manufacturing, and commercialization of neuro-interventional medical devices. Its extensive product range encompasses devices for ischemic stroke thrombectomy, intracranial stenosis intervention, ischemic stroke prevention, hemorrhagic stroke treatment, and vascular access. These medical technologies are utilized for both the prevention and treatment of ischemic stroke, including acute ischemic events and intracranial narrowing, as well as for addressing hemorrhagic stroke. Established in 2016 and previously operating as Shanghai Care Medical Technology Corporation Limited, the company maintains its headquarters in Shanghai, People's Republic of China.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| HK$82.67M-58.74% vs estimate |
| Q2 2024 | Aug 30, 2024 | -HK$0.15+17.65% vs estimate | HK$138.05M-11.57% vs estimate |
|---|
| Q1 2024 | May 20, 2024 | -HK$0.07 | HK$69.50M |
|---|
| Q4 2023 | Mar 28, 2024 | -HK$1.140.0% vs estimate | HK$135.05M+1.8% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥146.87+CN¥3.98 (+2.79%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 15.62% below the high.
CN¥49.14+CN¥0.52 (+1.07%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.03% below the high.
HK$51.80+HK$1.15 (+2.27%)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 35.64% below the high.
HK$1.53-HK$0.02 (-1.29%)
LifeTech Scientific Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.71% below the high.
HK$19.06-HK$0.16 (-0.83%)
Zylox-Tonbridge Medical Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.93% below the high.
HK$13.29-HK$0.96 (-6.74%)
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.88% below the high.
HK$5.33-HK$0.25 (-4.39%)
Acotec Scientific Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 65.21% below the high.
HK$0.96-HK$0.01 (-0.52%)
Shanghai Bio-heart Biological Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 89.21% below the high.
